The vote took place following a special board meeting on Feb. 1, according to a hospital news release.
Mr. Murdock has been serving as interim CEO since late December, when president and CEO Brian Dietz was suspended with pay through Feb. 5. The hospital said Mr. Dietz’s suspension with pay will now also continue until Feb. 20.
Effective Dec. 28, Mr. Dietz was suspended pending an investigation into recent allegations regarding hospital management.
In its news release, the hospital said it continues to process information from the investigation.
Mr. Dietz served as interim president and CEO of the hospital until he became its seventh CEO in April 2019. Mr. Murdock served as vice president and CFO until he was named interim CEO.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
